Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$626K Hold
2,236
0.31% 95
2026
Q1
$597K Sell
2,236
-21
-0.9% -$5.69K 0.33% 88
2025
Q4
$566K Sell
2,257
-161
-7% -$42.8K 0.32% 88
2025
Q3
$694K Sell
2,418
-125
-5% -$33.5K 0.38% 82
2025
Q2
$668K Sell
2,543
-137
-5% -$33.4K 0.39% 80
2025
Q1
$624K Hold
2,680
0.39% 81
2024
Q4
$615K Sell
2,680
-234
-8% -$53.7K 0.37% 84
2024
Q3
$651K Hold
2,914
0.38% 83
2024
Q2
$593K Buy
2,914
+3
+0.1% +$610 0.37% 85
2024
Q1
$636K Hold
2,911
0.4% 82
2023
Q4
$662K Hold
2,911
0.45% 77
2023
Q3
$585K Sell
2,911
-134
-4% -$28.3K 0.43% 78
2023
Q2
$631K Buy
3,045
+17
+0.6% +$3.3K 0.47% 69
2023
Q1
$597K Hold
3,028
0.47% 74
2022
Q4
$633K Buy
+3,028
New +$592K 0.52% 67

Other funds holding LH

ViaWealth's LH Position: Q2 2026 in Review

ViaWealth held its Labcorp (LH) position steady in Q2 2026 at 2,236 shares worth $626K. The position accounts for 0.31% of the portfolio, ranked #95.

ViaWealth first reported a position in LH in Q4 2022 and has held it in 15 quarters since. The position peaked at $694K in Q3 2025. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • ViaWealth held 2,236 shares of Labcorp worth $626K as of Q2 2026.
  • ViaWealth left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up 0.31% of ViaWealth's portfolio in Q2 2026, its #95 holding.
  • ViaWealth first reported a position in Labcorp in Q4 2022 and has held it in 15 quarters since.
  • ViaWealth's Labcorp position peaked at $694K in Q3 2025.
  • 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on ViaWealth's 13F filing for Q2 2026, filed 11 Aug 2026.